Inhibition of acetylpolyamine and spermine oxidases by the polyamine analogue chlorhexidine

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 3, 2013, Pages 463-467

  Cervelli, Manuela ^a   Polticelli, Fabio ^a,b   Fiorucci, Laura ^c   Angelucci, Emanuela ^a   Federico, Rodolfo ^a   Mariottini, Paolo ^a  

^a ROMA TRE UNIVERSITY   (Italy)

^b INFN SEZIONE DI ROMA   (Italy)

^c UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Acetylspermine oxidase; Chlorhexidine; Ki; Spermine oxidase

Indexed keywords

ACETYLPOLYAMINE OXIDOREDUCTASE; CHLORHEXIDINE; N,N' BIS(2,3 BUTADIENYL)PUTRESCINE; OXIDOREDUCTASE; SPERMINE OXIDOREDUCTASE; UNCLASSIFIED DRUG; ACETYLPOLYAMINE OXIDASE; SPERMINE OXIDASE;

ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG BINDING; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME INHIBITION; HYDROPHOBICITY; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL CELL; ENZYME BINDING; ENZYME SPECIFICITY; STEREOCHEMISTRY;

ANIMALS; CATALYTIC DOMAIN; CHLORHEXIDINE; ENZYME INHIBITORS; MICE; MODELS, MOLECULAR; MOLECULAR DOCKING SIMULATION; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PROTEIN CONFORMATION; PUTRESCINE;

EID: 84875394911     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2011.650691     Document Type: Article

References (25)

1. Seiler N. Catabolism of polyamines. Amino Acids 2004;26: 217-233.
2. Wallace HM, Fraser AV, Hughes A. A perspective of polyamine metabolism. Biochem J 2003;376:1-14.
3. CaseroRAJr, PeggAE. Spermidine/spermineN1-acetyltransferaseYthe turning point in polyamine metabolism. FASEB J 1993;7:653-661.
4. Wang Y, Devereux W, Woster PM, Stewart TM, Hacker A, Casero RA Jr. Cloning and characterization of a human polyamine oxidase that is inducible by polyamine analogue exposure. Cancer Res 2001;61:5370-5373.
5. Vujcic S, Diegelman P, Bacchi CJ, Kramer DL, Porter CW. Identification and characterization of a novel flavin-containing spermine oxidase of mammalian cell origin. Biochem J 2002;367:665-675.
6. Wu T, Yankovskaya V, McIntire WS. Cloning, sequencing, and heterologous expression of the murine peroxisomal flavoprotein, N1-acetylated polyamine oxidase. J Biol Chem 2003;278: 20514-20525.
7. Agostinelli E, Arancia G, Vedova LD, Belli F, Marra M, Salvi M et al. The biological functions of polyamine oxidation products by amine oxidases: Perspectives of clinical applications. Amino Acids 2004;27:347-358.
8. Casero RA Jr, Marton LJ. Targeting polyamine metabolism and function in cancer and other hyperproliferative diseases. Nat Rev Drug Discov 2007;6:373-390.
9. Amendola R, Cervelli M, Fratini E, Polticelli F, Sallustio DE, Mariottini P. Spermine metabolism and anticancer therapy. Curr Cancer Drug Targets 2009;9:118-130.
10. Casero RA, Pegg AE. Polyamine catabolism and disease. Biochem J 2009;421:323-338.
11. Cervelli M, Polticelli F, Federico R, Mariottini P. Heterologous expression and characterization of mouse spermine oxidase. J Biol Chem 2003;278:5271-5276.
12. Vujcic S, Liang P, Diegelman P, Kramer DL, Porter CW. Genomic identification and biochemical characterization of the mammalian polyamine oxidase involved in polyamine back-conversion. Biochem J 2003;370:19-28.
13. Wang Y, Murray-Stewart T, Devereux W, Hacker A, Frydman B, Woster PM et al. Properties of purified recombinant human polyamine oxidase, PAOh1/SMO. Biochem Biophys Res Commun 2003;304:605-611.
14. Bellelli A, Cavallo S, Nicolini L, Cervelli M, Bianchi M, Mariottini P et al. Mouse spermine oxidase: A model of the catalytic cycle and its inhibition by N,N1-bis(2,3-butadienyl)-1,4-butanediamine. Biochem Biophys Res Commun 2004;322:1-8.
15. Wang Y, Hacker A, Murray-Stewart T, Frydman B, Valasinas A, Fraser AV et al. Properties of recombinant human N1-acetylpolyamine oxidase (hPAO): Potential role in determining drug sensitivity. Cancer Chemother Pharmacol 2005;56:83-90.
16. Wu T, Ling KQ, Sayre LM, McIntire WS. Inhibition of murine N1-acetylated polyamine oxidase by an acetylenic amine and the allenic amine, MDL 72527. Biochem Biophys Res Commun 2005;326:483-490.
17. Binda C, Coda A, Angelini R, Federico R, Ascenzi P, Mattevi A. A 30-angstrom-long U-shaped catalytic tunnel in the crystal structure of polyamine oxidase. Structure 1999;7:265-276.
18. Binda C, Angelini R, Federico R, Ascenzi P, Mattevi A. Structural bases for inhibitor binding and catalysis in polyamine oxidase. Biochemistry 2001;40:2766-2776.
19. Huang Q, Liu Q, Hao Q. Crystal structures of Fms1 and its complex with spermine reveal substrate specificity. J Mol Biol 2005;348:951-959.
20. Bianchi M, Polticelli F, Ascenzi P, Botta M, Federico R, Mariottini P et al. Inhibition of polyamine and spermine oxidases by polyamine analogues. FEBS J 2006;273:1115-1123.
21. Tavladoraki P, Cervelli M, Antonangeli F, Minervini G, Stano P, Federico R et al. Probing mammalian spermine oxidase enzymesubstrate complex through molecular modeling, site-directed mutagenesis and biochemical characterization. Amino Acids 2011;40:1115-1126.
22. Bey P, Bolkenius FN, Seiler N, Casara P. N-2,3-Butadienyl-1,4- butanediamine derivatives: Potent irreversible inactivators of mammalian polyamine oxidase. J Med Chem 1985;28:1-2.
23. Gendron R, Grenier D, Sorsa T, Mayrand D. Inhibition of the activities of matrix metalloproteinases 2, 8, and 9 by chlorhexidine. Clin Diagn Lab Immunol 1999;6:437-439.
24. Cronan CA, Potempa J, Travis J, Mayo JA. Inhibition of Porphyromonas gingivalis proteinases (gingipains) by chlorhexidine: Synergistic effect of Zn(II). Oral Microbiol Immunol 2006;21:212-217.
25. Trott O, Olson AJ. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 2010;31:455-461.